Marshall Wace, LLP Enovis Corp Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $511,544 - $588,682	9,227 New	9,227 $576,000
Q2 2023 Aug 14, 2023	BUY	$52.7 - $64.12 $6.58 Million - $8.01 Million	124,935 New	124,935 $8.01 Million
Q3 2022 Nov 14, 2022	SELL	$46.07 - $60.1 $146,502 - $191,118	-3,180 Reduced 17.93%	14,551 $670,000
Q2 2022 Aug 15, 2022	SELL	$55.0 - $70.47 $5.34 Million - $6.84 Million	-97,097 Reduced 84.56%	17,731 $975,000
Q1 2022 May 16, 2022	BUY	$62.07 - $80.84 $7.13 Million - $9.28 Million	114,828 New	114,828 $4.57 Million

310

60.3M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.51B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.